Toggle SGML Header (+)


Section 1: 8-K (JAS Q1 FY19 EARNINGS SLIDES)


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934
 
 
 
Date of Report (Date of earliest event reported)
October 19, 2018
 
 
 
 
THE PROCTER & GAMBLE COMPANY
(Exact name of registrant as specified in its charter)
 
Ohio
 
1-434
 
31-0411980
(State or other jurisdiction
of incorporation)
 
(Commission File Number)
 
(IRS Employer
Identification Number)
 
One Procter & Gamble Plaza, Cincinnati, Ohio
 
45202
(Address of principal executive offices)
 
Zip Code
 
(513) 983-1100
 
45202
(Registrant's telephone number, including area code)
 
Zip Code
 
 
 
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
 
                                                                                                                                                                                                                            Emerging growth company
       
  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ☐ 
                                                                                                                                  
 
 
 
ITEM 7.01    REGULATION FD DISCLOSURE
 
On October 19, 2018, The Procter & Gamble Company (the "Company") issued a press release announcing its first quarter results and hosted a conference call related to those results.  The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website.
 
This 8-K is being furnished pursuant to Item 7.01, "Regulation FD Disclosure."
 
ITEM 9.01    FINANCIAL STATEMENTS AND EXHIBITS
 
(d) Exhibits
 
Exhibit Number
 
Description
99.1
 
Informational Slides Provided by The Procter & Gamble Company dated October 19, 2018
 
 SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
THE PROCTER & GAMBLE COMPANY
 
 
BY:  /s/ Sandra T. Lane                    
                Sandra T. Lane
              Assistant Secretary
              October 19, 2018
 
 
INDEX TO EXHIBIT(S)
 
Exhibit Number
 
Description
 
 


(Back To Top)

Section 2: EX-99.1 CHARTER (JAS Q1 FY19 EARNINGS SLIDES)

 *  Earnings ReleaseQ1 FY 2019 ResultsOctober 19, 2018 
 



 Q1 Fiscal Year 2019 HIGHLIG
 First Quarter FY 2019  Organic Sale
 *  Jul – Sep 18 (Q1 FY 19) ResultsORGANIC SALES RESULTS  Organic sales growth was primarily volume driven, with organic volume up more than +3%. Mix contributed +1%. Pricing was neutral to the quarter. 
 

 *  Jul – Sep 18 (Q1 FY 19) ResultsCORE EPS GROWTH  Core gross margin contracted 150 basis points, as 170 basis points of productivity improvements were offset by 100 points of commodity cost increases, 60 points of foreign exchange headwinds…and 160 points of negative mix, innovation investments and other impacts. Core operating margin decreased 80 basis points, including 250 points of productivity savings.  
 

 *  Jul – Sep 18 (Q1 FY 19) ResultsCURRENCY-NEUTRAL CORE EPS GROWTH  Constant currency core operating margin increased 50 basis points. Excluding currency and commodities, core operating margin was up 150 points. 
 

 *  Business Segment Results and HighlightsQ1 FY 2019 
 

 *  +2% Pricing, +3% MixOrganic Sales: h Mid-single digits in Developed markets, h Double digits in Developing marketsGlobal value share flat versus year agoNet Earnings: Volume growth, pricing, favorable product mix and tax help were partially offset by currency headwinds.  Jul – Sep 18 (Q1 FY 19) ResultsBEAUTY SEGMENT 
 

 *  Hair Care organic sales grew low single digits versus year ago. Developed markets were up low single digits behind premium innovation and strong retail execution. Developing markets were up mid-single digits driven by premium innovation, increased pricing and strong retail execution.Skin & Personal Care organic sales grew double digits versus year ago. Skin Care sales grew double digits and Personal Care sales grew mid-single digits. Developing markets were up double digits led by strong growth in China on both Olay Skin and SK-II. Developed markets were up high single digits led by premium product innovation in Skin and Personal Care and double digit SK-II growth in Japan.  By Category  Organic Sales Growth IYA  Organic Sales Growth IYA  Organic Sales Growth IYA  By Category  Global  Developed  Developing  Hair Care  +  ~=  +  Skin & Personal Care  +  +  +   + represents growth above 1%, ~= represents growth of 1% to decline of 1%; - represents decline greater than 1%.  Jul – Sep 18 (Q1 FY 19) ResultsBEAUTY HIGHLIGHTS 
 

 *  +1% Pricing, -2% Mix Organic Sales: h Low single digits in Developed markets, h Mid-single in Developing marketsGlobal value share declined 0.7 points versus year ago. Sub-category mix reduced total grooming share. Global Shave share up 0.1 points versus year ago. Global Appliances share down 0.6 points versus year ago.Net Earnings: Volume growth, devaluation pricing, productivity savings and tax help were partially offset by commodity and currency headwinds and unfavorable mix.  Jul – Sep 18 (Q1 FY 19) ResultsGROOMING SEGMENT 
 

 *  *  Grooming organic sales increased mid-single digits versus year ago. Shave Care sales were up low single digits in Developed markets behind strong retail execution including in-store merchandising support and investments in direct-to-consumer programs. Developing markets were up mid-single digits behind investments in strong retail execution and devaluation pricing. Appliance sales increased low single digits related to improved merchandising programs and underlying market growth.  By Category  Organic Sales Growth IYA  Organic Sales Growth IYA  Organic Sales Growth IYA  By Category  Global  Developed  Developing  Grooming  +  +  +  Jul – Sep 18 (Q1 FY 19) ResultsGROOMING HIGHLIGHTS   + represents growth above 1%, ~= represents growth of 1% to decline of 1%; - represents decline greater than 1%. 
 

 *  Flat Pricing, -1% MixOrganic Sales: h Mid-single digits in Developed markets, h Mid-single digits in Developing marketsGlobal value share increased 0.4 point versus year agoNet Earnings: Volume growth and tax help were partially offset by unfavorable geography mix and commodity and currency headwinds.   Jul – Sep 18 (Q1 FY 19) ResultsHEALTH CARE SEGMENT 
 

 *  *  Oral Care organic sales increased low single digits versus year ago. Developed markets grew low single digits with growth in power toothbrushes and premium toothpaste innovation partially offset by the reversal of a U.S. toothpaste list price increase in the base year. Developing markets were flat with growth in premium toothpaste offset by declines on low-tier toothpaste in China.Personal Health Care organic sales increased double digits versus year ago due to innovation driven volume, marketing investments and price increases across markets. Vicks organic sales grew in the teens.  By Category  Organic Sales Growth IYA  Organic Sales Growth IYA  Organic Sales Growth IYA  By Category  Global  Developed  Developing  Oral Care  ~=  +  ~=  Personal Health Care  +  +  +   + represents growth above 1%, ~= represents growth of 1% to decline of 1%; - represents decline greater than 1%.  Jul – Sep 18 (Q1 FY 19) ResultsHEALTH CARE HIGHLIGHTS 
 

 *  -1% Pricing, +1 MixOrganic Sales: h Mid-single digits in Developed markets, h Mid-single digits in Developing marketsGlobal value share increased 0.5 points versus year agoNet Earnings: Innovation driven volume growth, productivity improvements and tax help were partially offset by more profitable, but lower margin product mix hurt, consumer and customer value investments and commodity and currency headwinds.   Jul – Sep 18 (Q1 FY 19) ResultsFABRIC & HOME SEGMENT 
 

 *  *  Fabric Care organic sales grew mid-single digits versus year ago. Developed markets increased mid-single digits behind innovation driven volume growth across laundry and fabric enhancers. Developing markets increased mid-single digits driven by premium innovation and devaluation pricing.Home Care organic sales increased mid-single digits versus year ago with strong growth across all segments. Strength driven by innovation driven volume, strengthened retail execution including enhanced merchandising programs and increased investments in brand communication.    + represents growth above 1%, ~= represents growth of 1% to decline of 1%; - represents decline greater than 1%.  By Category  Organic Sales Growth IYA  Organic Sales Growth IYA  Organic Sales Growth IYA  By Category  Global  Developed  Developing  Fabric Care  +  +  +  Home Care  +  +  +  Jul – Sep 18 (Q1 FY 19) ResultsFABRIC & HOME HIGHLIGHTS 
 

 *  -1% Pricing, Flat MixOrganic Sales: h Low single digits in Developed markets, i Low single digits in Developing marketsGlobal value share declined 0.2 points versus year agoNet Earnings: Volume growth, productivity savings and tax help were partially offset by commodity and currency headwinds and consumer and customer value investments.  Jul – Sep 18 (Q1 FY 19) ResultsBABY, FEMININE and FAMILY CARE SEGMENT 
 


 *  *  Baby Care organic sales declined mid-single digits versus year ago in both Developed and Developing markets. Growth on premium taped diapers and pants were offset by softness on mid-tier and value-tier diapers in the U.S. and China. Feminine Care organic sales increased mid-single digits versus year ago led by growth on premium innovation and favorable product mix from Always Discreet growth.Family Care organic sales increased mid-single digits versus year ago led by innovation driven volume, increased distribution and strengthened merchandizing programs.   By Category  Organic Sales Growth IYA  Organic Sales Growth IYA  Organic Sales Growth IYA  By Category  Global  Developed  Developing  Baby Care  -  -  -  Feminine Care  +  +  +  Family Care  +  +  N.A.   + represents growth above 1%, ~= represents growth of 1% to decline of 1%; - represents decline greater than 1%.  Jul – Sep 18 (Q1 FY 19) ResultsBABY, FEMININE and FAMILY CARE HIGHLIGHTS 
 FY 2019 Guidance 

 
   FY ‘19  Core EPS Growth  +3% to +8%  All-in EPS Growth  +17% to +24%  Core EPS growth of +3% to +8% (no change vs. prior outlook)Expect net impact of interest expense, interest income and non-operating income to be a two point drag on EPS growthCore effective tax rate range of 19% to 20%~2% reduction on average diluted shares outstanding  FY 2019 GuidanceCORE EPS 

 *   Adjusted Free Cash Flow Productivity: 90%+Capital Spending, % Sales: 5% to 5.5%Dividends: Over $7BDirect Share Repurchase: Up to $5B** Factors in cash required to complete the acquisition of Merck’s OTC business during the year and cash spent on other deals.  FY 2019 GuidanceCASH GENERATION AND USAGE 

 *  Significant deceleration of market growth ratesSignificant currency weaknessFurther commodity cost increasesFurther political and economic volatility  FY 2019 GuidancePOTENTIAL HEADWINDS NOT INCLUDED IN GUIDANCE 
 

 *  Additional Information 
 





The Procter & Gamble Company Regulation G Reconciliation of Non-GAAP Measures
 
In accordance with the SEC's Regulation G, the following provides definitions of the non-GAAP measures used in Procter & Gamble's October 19, 2018 earnings call, associated slides, and other materials and the reconciliation to the most closely related GAAP measure. We believe that these measures provide useful perspective on underlying business trends (i.e. trends excluding non-recurring or unusual items) and results and provide a supplemental measure of year-on-year results. The non-GAAP measures described below are used by Management in making operating decisions, allocating financial resources and for business strategy purposes. These measures may be useful to investors as they provide supplemental information about business performance and provide investors a view of our business results through the eyes of Management. Certain of these measures are also used to evaluate senior management and are a factor in determining their at-risk compensation. These non-GAAP measures are not intended to be considered by the user in place of the related GAAP measure, but rather as supplemental information to our business results.  These non-GAAP measures may not be the same as similar measures used by other companies due to possible differences in method and in the items or events being adjusted.

The measures provided are as follows:
1.
Organic sales growth — page 3
2.
Core EPS and currency-neutral Core EPS — pages 4
3.
Core operating profit margin, constant currency Core operating profit margin, and Core operating profit margin excluding currency and commodities — page 5
4.
Core gross margin and Core gross margin excluding currency and commodities — page 5
5.
Core SG&A margin and currency neutral SG&A margin – page 5
6.
Adjusted free cash flow — page 6
7.
Adjusted free cash flow productivity — page 6
8.
Core cost of products sold — page 6
9.
Core SG&A expense — page 6
10.
Core other non-operating income — page 7

Organic sales growth*:  Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions and divestitures, the impact from the July 1, 2018 adoption of new accounting standards for "Revenue from Contracts with Customers", the impact from India Goods and Services Tax changes (which were effective on July 1, 2017) and foreign exchange from year-over-year comparisons. Management believes this measure provides investors with a supplemental understanding of underlying sales trends by providing sales growth on a consistent basis.

The Core earnings measures included in the following reconciliation tables refer to the equivalent GAAP measures adjusted as applicable for the following items:
Incremental restructuring:  The Company has had and continues to have an ongoing level of restructuring activities.  Such activities have resulted in ongoing annual restructuring related charges of approximately $250 - $500 million before tax. In 2012 the Company began a $10 billion strategic productivity and cost savings initiative that included incremental restructuring activities.  In 2017, the Company communicated details of an additional multi-year productivity and cost savings plan.  This results in incremental restructuring charges to accelerate productivity efforts and cost savings.  The adjustment to Core earnings includes only the restructuring costs above what we believe are the normal recurring level of restructuring costs.
Gain on Dissolution of the PGT Healthcare Partnership: The Company finalized the dissolution of our PGT Healthcare partnership, a venture between the Company and Teva Pharmaceuticals Industries, Ltd (Teva) in the OTC consumer healthcare business, in the quarter ended September 30, 2018. The transaction was accounted for as a sale of the Teva portion of the PGT business; the Company recognized an after-tax gain on the dissolution of $353 million.
Transitional Impact of U.S. Tax Reform:  In December 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the "U.S. Tax Act").  This resulted in a net charge of $602 million for the fiscal year 2018.  The adjustment to Core earnings only includes this transitional impact.  It does not include the ongoing impacts of the lower U.S. statutory rate on current year earnings.
Early debt extinguishment charges:  In fiscal 2018 and 2017, the Company recorded after-tax charges of $243 million and $345 million, respectively, due to the early extinguishment of certain long-term debt.  These charges represent the difference between the reacquisition price and the par value of the debt extinguished. Management does not view this charge as indicative of the Company's operating performance or underlying business results.

We do not view the above items to be part of our sustainable results, and their exclusion from core earnings measures provides a more comparable measure of year-on-year results. These items are also excluded when evaluating senior management in determining their at-risk compensation. Management views the following non-GAAP measures as useful supplemental measures of Company performance and operating efficiency over time.

Core EPS and currency-neutral Core EPS*:  Core earnings per share, or Core EPS, is a measure of the Company's diluted net earnings per share from continuing operations adjusted as indicated.  Currency-neutral Core EPS is a measure of the Company's Core EPS excluding the incremental current year impact of foreign exchange.

Core operating profit margin*: Core operating profit margin is a measure of the Company's operating margin adjusted for items as indicated.

Currency-neutral Core operating profit margin*: Currency-neutral Core operating profit margin is a measure of the Company's Core operating profit margin excluding the incremental current year impact of foreign exchange.

Core operating profit margin excluding currency and commodities: Core operating profit margin excluding currency and commodities is a measure of the Company's Core operating profit margin excluding the incremental current year impact of foreign exchange and commodities.

Core gross margin: Core gross margin is a measure of the Company's gross margin adjusted for items as indicated.

Core gross margin excluding currency and commodities: Core gross margin excluding currency and commodities is a measure of the Company's gross margin excluding current year impact of foreign exchange and commodities.

Core selling, general and administrative (SG&A) expense as a percentage of net sales: Core SG&A expense as a percentage of net sales is a measure of the Company's selling, general and administrative expenses adjusted for items as indicated.

Currency-neutral Core SG&A expense as a percentage of net sales: Currency-neutral Core SG&A expense as a percentage of net sales is a measure of the Company's Core SG&A expense as a percentage of net sales excluding the incremental current year impact of foreign exchange.

Adjusted free cash flow:  Adjusted free cash flow is defined as operating cash flow less capital spending and excluding payments for the transitional tax resulting from the comprehensive U.S. legislation commonly referred to as the Tax Cut and Jobs Act in December 2017 (the U.S. Tax Act). Adjusted free cash flow represents the cash that the Company is able to generate after taking into account planned maintenance and asset expansion.  Management views adjusted free cash flow as an important measure because it is one factor used in determining the amount of cash available for dividends, share repurchases, acquisitions and other discretionary investment.

Adjusted free cash flow productivity*:  Adjusted free cash flow productivity is defined as the ratio of adjusted free cash flow to net earnings excluding the gain on dissolution of the PGT Healthcare partnership, which is non-recurring and not considered indicative of underlying cash flow performance.  Management views adjusted free cash flow productivity as a useful measure to help investors understand P&G's ability to generate cash. Adjusted free cash flow productivity is used by management in making operating decisions, allocating financial resources and for budget planning purposes.  The Company's long-term target is to generate annual free cash flow productivity at or above 90 percent.

Core cost of products sold: Core cost of products sold is a measure of the Company's cost of products sold adjusted for items as such indicated.

Core SG&A expense: Core SG&A expense is a measure of the Company's SG&A expense adjusted for items as such indicated.

Core other non-operating income: Core other non-operating income is a measure of the Company's other non-operating income adjusted for items as such indicated.

* Measure is used to evaluate senior management and is a factor in determining their at-risk compensation.
 
 
1. Organic sales growth:
 
Three Months Ended
September 30, 2018
Net Sales Growth
 
Foreign Exchange Impact
 
Acquisition &
Divestiture Impact/Other*
 
Organic Sales Growth
Beauty
5%
 
3%
 
(1)%
 
7%
Grooming
(1)%
 
4%
 
1%
 
4%
Health Care
(3)%
 
2%
 
5%
 
4%
Fabric Care & Home Care
2%
 
2%
 
1%
 
5%
Baby, Feminine & Family Care
(3)%
 
2%
 
-%
 
(1)%
Total P&G
-%
 
3%
 
1%
 
4%
* Acquisition & Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures, the impact from the July 1, 2018 adoption of new accounting standards for "Revenue from Contracts with Customers" and rounding impacts necessary to reconcile net sales to organic sales.



Organic Sales
Prior Periods

 
Total Company
Net Sales Growth
 
Foreign Exchange Impact
 
Acquisition/ Divestiture Impact*
 
Organic Sales Growth
JAS 2017
1%
 
-%
 
-%
 
1%
OND 2017
3%
 
(1)%
 
-%
 
2%
JFM 2018
4%
 
(4)%
 
1%
 
1%
AMJ 2018
3%
 
(2)%
 
-%
 
1%
* Acquisition & Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures for all periods, the impact of India Goods and Services Tax implementation in FY 2018 and rounding impacts necessary to reconcile net sales to organic sales.



Organic Sales
Guidance
Total Company
 
Net Sales Growth
 
Combined Foreign Exchange &
Acquisition/Divestiture Impact*
 
Organic Sales Growth
FY 2019 (Estimate)
 
(2)% to 0%
 
4% to 3%
 
+2% to +3%
* Acquisition & Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures, the impact from the July 1, 2018 adoption of new accounting standards for "Revenue from Contracts with Customers" and rounding impacts necessary to reconcile net sales to organic sales.


 
 
2. Core EPS and currency-neutral Core EPS: 
 
Three Months Ended
September 30
 
2018
 
2017
Diluted Net Earnings Per Share from Continuing Operations
$1.22
 
$1.06
  Incremental Restructuring
0.03
 
0.03
  Gain on Dissolution of PGT Partnership
(0.14)
   
  Rounding
0.01
   
Core EPS
$1.12
 
$1.09
Percentage change vs. prior period
3%
   
Currency Impact to Earnings
0.09
   
Currency-Neutral Core EPS
$1.21
   
Percentage change vs. prior period Core EPS
11%
   

Note – All reconciling items are presented net of tax. Tax effects are calculated consistent with the nature of the underlying transaction.

Core EPS
Guidance
Total Company
Diluted EPS Growth
Impact of Incremental
Non-Core Items*
Core EPS Growth
FY 2019 (Estimate)
+17% to +24%
(14)% to (16)%
+3% to +8%
* Includes the gain on the dissolution of the PGT Healthcare partnership in 2019 and the impact of U.S. Tax Act and loss on early extinguishment of debt in 2018 and year-over-year changes in incremental non-core restructuring charges.

Core EPS
Prior Quarters

 
JAS 17
JAS 16
OND 17
OND 16
JFM 18
JFM 17
AMJ 18
AMJ 17
Diluted Net Earnings Per Share from Continuing Operations,
attributable to P&G
$    1.06
$    1.00
$    0.93
$    0.93
$    0.95
$    0.93
$    0.72
$    0.82
Incremental Restructuring
0.03
0.03
0.02
0.03
0.04
0.03
0.14
0.02
Early Debt Extinguishment Charges
-
-
-
0.13
-
-
0.09
-
Transitional Impact of U.S. Tax Reform
-
-
0.24
 
0.01
 
(0.02)
 
Rounding
-
-
-
(0.01)
-
-
0.01
0.01
Core EPS
$    1.09
$    1.03
$    1.19
$    1.08
$    1.00
$    0.96
$    0.94
$    0.85
Percentage change vs. prior period
6%
 
10%
 
4%
 
11%
 
Currency Impact to Earnings
-
 
(0.04)
 
(0.03)
 
0.01
 
Currency-Neutral Core EPS
$    1.09
 
$    1.15
 
$    0.97
 
$    0.95
 
Percentage change vs. prior period Core EPS
6%
 
6%
 
1%
 
12%
 
 
3. Core operating profit margin, constant currency core operating profit margin, and core operating profit margin excluding currency and commodities: 
 
 
Three Months Ended
September 30
 
2018
2017
Operating Profit Margin
21.3%
21.9%
  Incremental Restructuring
0.4%
0.6%
  Rounding
-%
-%
Core Operating Profit Margin
21.7%
22.5%
Basis point change vs. prior year Core margin
(80)
 
Currency Impact to Margin
1.3%
 
Constant Currency Core Operating Profit Margin
23.0%
 
Basis point change vs. prior year Core margin
50
 
Commodity Impact to Margin
1.0%
 
Core Operating Profit Margin Excluding Currency and Commodities
24.0%
 
Basis point change vs prior year Core margin
150
 



4. Core gross margin, and core gross margin excluding currency and commodities: 

 
Three Months Ended
September 30
 
2018
2017
Gross Margin
49.2%
50.3%
  Incremental Restructuring
0.3%
0.6%
  Rounding
(0.1)%
-%
Core Gross Margin
49.4%
50.9%
Basis point change vs. prior year Core margin
(150)
 
Currency Impact to Margin
0.6%
 
Constant Currency Core Gross Margin
50.0%
 
Basis point change vs. prior year Core margin
(90)
 
Commodity Impact to Margin
1.0%
 
Core Gross Margin Excluding Currency and Commodities
51.0%
 
Base point change vs prior year Core Margin
10
 


5. Core SG&A margin and constant currency core SG&A margin:

 
Three Months Ended
September 30
 
2017
2016
SG&A as a percentage of net sales
27.9%
28.4%
  Incremental Restructuring
(0.2)%
-%
  Rounding
-%
0.1%
Core SG&A as a percentage of net sales
27.7%
28.5%
Basis points change vs. prior period
(80)
 
Currency Impact to SG&A as a percentage of net sales
(0.7)%
 
Constant Currency Core SG&A as a percentage of net sales
27.0%
 
Basis point change vs prior year SG&A as a percentage of net sales
(150)
 

 


6. Adjusted free cash flow (dollar amounts in millions): 

Three Months Ended September 30, 2018
Operating Cash Flow
Capital Spending
US Tax Act Payments
Adjusted Free Cash Flow
$3,567
$(1,080)
$235
$2,722




7. Adjusted free cash flow productivity (dollar amounts in millions):

Three Months Ended September 30, 2018
Adjusted Free Cash Flow
Net Earnings
Gain on Dissolution of PGT Partnership
Adjusted Net Earnings
Adjusted Free Cash Flow Productivity
$2,722
$3,211
$(353)
$2,858
95%




8. Core cost of products sold (dollar amounts in millions):

Core Cost of Products Sold
FY 1718

 
Total Company
Cost of Products Sold
 
Incremental Restructuring
 
Rounding
 
Core Cost of Products Sold
JAS 2017
8,269
 
(100)
 
-
 
8,169
OND 2017
8,709
 
(86)
 
1
 
8,624
JFM 2018
8,384
 
(110)
 
(1)
 
8,273
AMJ 2018
9,070
 
(428)
 
(1)
 
8,641
FY 2018
34,432
 
(724)
 
(1)
 
33,707




9. Core SG&A Expense (dollar amounts in millions):

Core SG&A Expense
FY 1718

 
Total Company
SG&A Expense
 
Incremental Restructuring
 
Rounding
 
Core SG&A Expense
JAS 2017
4,736
 
7
 
-
 
4,743
OND 2017
4,767
 
19
 
(1)
 
4,785
JFM 2018
4,688
 
(24)
 
-
 
4,664
AMJ 2018
4,846
 
(3)
 
2
 
4,845
FY 2018
19,037
 
(1)
 
1
 
19,037









10. Core other non-operating income (dollar amounts in millions):

Core Other Non-Operating Income
FY 1718

 
Total Company
Other Non-Operating Income
 
Incremental Restructuring
 
Early Debt Extinguishment
 
Core Other Non-Operating Income
JAS 2017
169
 
2
 
-
 
171
OND 2017
170
 
5
 
-
 
175
JFM 2018
108
 
4
 
-
 
111
AMJ 2018
(225)
 
3
 
346
 
124
FY 2018
222
 
14
 
346
 
581




 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

(Back To Top)